Cargando...
The Protease Inhibitors and HIV Associated Bone Loss
PURPOSE OF REVIEW: HIV infection is an established risk factor for osteoporosis and bone fracture. Combination antiretroviral therapy (cART) increases bone resorption leading to an additional 2–6% bone mineral density (BMD) loss within the first 1–2 years of therapy. While tenofovir disoproxil fumar...
Guardado en:
| Publicado en: | Curr Opin HIV AIDS |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4838480/ https://ncbi.nlm.nih.gov/pubmed/26918650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0000000000000260 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|